# Non-Muscle Invasive Bladder trials recruiting: 22 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 22 trials with no drug phase for Non-Muscle Invasive Bladder Neoplasms that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Non-Muscle Invasive Bladder Neoplasms trials with no drug phase: 22 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/not-applicable/non-muscle-invasive-bladder-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 22
- Recruiting or not yet: 22
- Read on: November 19, 2026

## Trials

The 22 newest of 22, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 9, 2026 | NCT07924046 | Diagnostic Performance of Multiparametric Magnetic Resonance Imaging After Transurethral Resection of Bladder Tumour for Prediction of... | University of Lausanne Hospitals | Not applicable | Not yet recruiting | Urinary Bladder Cancer, NMIBC, TURBT, Vi-Rads | 86 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924046) |
| October 14, 2026 | NCT07873333 | The Role of Definitive Radiotherapy in Non Muscle Invasive Bladder Cancer | Assiut University | Not applicable | Not yet recruiting | Non Muscle Invasive Bladder Cancer | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07873333) |
| October 6, 2026 | NCT07860398 | Feasibility of Automatic, Laser-based Distance Control in Persons With Superficial Bladder Tumors | Sponsor not shown (see the record) | Not applicable | Recruiting | NMIBC | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07860398) |
| September 14, 2026 | NCT07817173 | Feasibility of HISA During TURBT for NMIBC | CAMC Health System | Not applicable | Not yet recruiting | Bladder Cancer, Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy), Non-muscle Invasive Bladder... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07817173) |
| August 24, 2026 | NCT07781956 | Home-Based Supportive Care Program for NMIBC Patients Receiving Intravesical Perfusion: Construction and Preliminary Application | Nanjing First Hospital, Nanjing Medical University | Not applicable | Not yet recruiting | Non-Muscle-Invasive Bladder Cancer (NMIBC) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07781956) |
| August 11, 2026 | NCT07758881 | Evaluating the Safety and Performance of the Eight Medical Hyperthermia System IV 1.0 for HIVEC in NMIBC. | Eight Medical International BV | Not applicable | Not yet recruiting | Non-muscle Invasive Bladder Cancer (NMIBC) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07758881) |
| August 6, 2026 | NCT07749924 | Active Surveillance Versus Adjuvant Intravesical Chemotherapy in Liquid Biopsy-Defined Low-Shedding Intermediate-Risk NMIBC | Tianjin Medical University Second Hospital | Not applicable | Recruiting | Bladder Cancer, Non-Muscle-Invasive Bladder Cancer (NMIBC) | 670 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07749924) |
| July 27, 2026 | NCT07728474 | LCS103 Herbal Formula for Secondary Prevention of Non-Muscle Invasive Urothelial Carcinoma of the Bladder | LifeBiotic Medical Research Ltd. | Not applicable | Recruiting | Non-muscle Invasive Bladder Cancer (NMIBC) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07728474) |
| March 27, 2026 | NCT07495072 | Early vs Delayed Intravesical Blad-Care During BCG Therapy | BLAD-HYA Group | Not applicable | Recruiting | Urinary Bladder Neoplasms, BCG-Induced Cystitis | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07495072) |
| January 14, 2026 | NCT07339761 | Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study | University of Aarhus | Not applicable | Recruiting | Bladder Cancer, Non-Muscle-Invasive Bladder Cancer (NMIBC), Muscle-Invasive Bladder Carcinoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07339761) |
| November 17, 2025 | NCT07231809 | Hyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC Patients | AC.TA. S.r.l. | Not applicable | Not yet recruiting | Non Muscle Invasive Bladder Cancer, Bladder Cancer, Carcinoma in Situ of Bladder, Urinary Bladder Neoplasms, Carcinoma... | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07231809) |
| September 22, 2025 | NCT07187063 | Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer | Lahey Clinic | Not applicable | Recruiting | Non-muscle Invasive Bladder Cancer (NMIBC) | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07187063) |
| June 25, 2025 | NCT07036731 | A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative... | The First Affiliated Hospital with Nanjing Medical University | Not applicable | Recruiting | Non Muscle Invasive Bladder Cancer | 428 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07036731) |
| May 25, 2025 | NCT06990061 | Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer: an Open-label, Single-arm, Multicentre, Phase... | European Organisation for Research and Treatment of Cancer - EORTC | Not applicable | Recruiting | Non-Muscle Invasive Bladder Cancer | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06990061) |
| May 21, 2025 | NCT06982690 | Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial | National Taiwan University Hospital | Not applicable | Not yet recruiting | NMIBC, TURBT, Bladder (Urothelial, Transitional Cell) Cancer, Bladder Cancer Recurrence, Anesthesia, General... | 370 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06982690) |
| March 21, 2025 | NCT06889623 | Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer | Changhai Hospital | Not applicable | Recruiting | NMIBC | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06889623) |
| December 16, 2024 | NCT06735287 | A Bladder-Sparing Treatment Strategies of Large-Volume Non-Muscle-Invasive Bladder Cancer | The First Affiliated Hospital with Nanjing Medical University | Not applicable | Recruiting | Bladder Cancer, NMIBC | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06735287) |
| November 7, 2024 | NCT06678633 | T-Control® Safety for Cytostatics Management | Rethink Medical SL | Not applicable | Not yet recruiting | Non-muscle-invasive Bladder Cancer | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06678633) |
| March 1, 2024 | NCT06287541 | The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker... | The First Affiliated Hospital with Nanjing Medical University | Not applicable | Recruiting | Non Muscle Invasive Bladder Cancer | 428 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06287541) |
| February 7, 2024 | NCT06245603 | A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or... | Istituto Oncologico Veneto IRCCS | Not applicable | Recruiting | Non-muscle Invasive Bladder Cancer | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06245603) |
| March 30, 2023 | NCT05790850 | Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial) | University of Virginia | Not applicable | Recruiting | Bladder Cancer, Non-muscle-invasive Bladder Cancer, Muscle-Invasive Bladder Carcinoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05790850) |
| July 19, 2022 | NCT05464576 | Tumor Staging T of Bladder Tumours: Correlation of MRI and Anatomopathologic Analysis | University Hospital, Clermont-Ferrand | Not applicable | Recruiting | Urinary Bladder Tumour, MRI, Invasion, Diagnosis | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05464576) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| The First Affiliated Hospital with Nanjing Medical University | 3 |
| Rethink Medical SL | 1 |
| University Hospital, Clermont-Ferrand | 1 |
| Lahey Clinic | 1 |
| LifeBiotic Medical Research Ltd. | 1 |
| University of Aarhus | 1 |
| CAMC Health System | 1 |
| Eight Medical International BV | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| University of Virginia | 1 |
| Nanjing First Hospital, Nanjing Medical University | 1 |
| National Taiwan University Hospital | 1 |
| Istituto Oncologico Veneto IRCCS | 1 |
| Changhai Hospital | 1 |
| Tianjin Medical University Second Hospital | 1 |
| AC.TA. S.r.l. | 1 |
| Assiut University | 1 |
| University of Lausanne Hospitals | 1 |
| BLAD-HYA Group | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 6 |
| United States | 3 |
| Denmark | 2 |
| Belgium | 2 |
| Italy | 2 |
| France | 1 |
| Israel | 1 |
| Taiwan | 1 |
| South Korea | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Pool cleaning companies in the United States](https://specstream.ai/data/businesses/pool-cleaning-companies/united-states)
- [Medical testing laboratories in the United States](https://specstream.ai/data/businesses/medical-testing-laboratories/united-states)
- [Housing or property companies in the United States](https://specstream.ai/data/businesses/housing-or-property-companies/united-states)
- [Event technology companies in the United States](https://specstream.ai/data/businesses/event-technology-companies/united-states)
- [Comfort food restaurants in the United States](https://specstream.ai/data/businesses/comfort-food-restaurants/united-states)
- [B2B signage companies in the United States](https://specstream.ai/data/businesses/b2b-signage-companies/united-states)
